Envoy Medical
COCH
33 hedge funds and large institutions have $11.5M invested in Envoy Medical in 2026 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 6 closing their positions.
1,041% more capital invested
Capital invested by funds: $1.01M → $11.5M (+$10.5M)
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
133% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 6
22% more funds holding
Funds holding: 27 → 33 (+6)
17.22% more ownership
Funds ownership: 5.27% → 22.49% (+17%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$5.22M |
| 2 |
BL
Bleichroeder LP
New York
|
+$4.26M |
| 3 |
DCA
DSG Capital Advisors
Edina,
Minnesota
|
+$426K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$289K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$75.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$58.5K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$57.1K |
| 3 |
Corient Private Wealth
Miami,
Florida
|
-$50.5K |
| 4 |
VF
Virtu Financial
New York
|
-$23K |
| 5 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
-$12.6K |
COCH Hedge Fund Activity: Q1 2026 in Review
33 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q1 2026, worth a combined $11.5M — up 1,041% from $1.01M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new COCH positions and 6 closed out — a net gain of 8 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $5.22M. The largest seller was Citadel Advisors, exiting entirely with an estimated $58.5K sold.
- 33 institutional investors held Envoy Medical (COCH) as of Q1 2026, up from 27 in Q4 2025.
- Funds reported $11.5M of Envoy Medical stock for Q1 2026, up 1,041% quarter-over-quarter.
- 14 funds opened new Envoy Medical positions in Q1 2026 and 6 closed out, a net change of +8 holders.
- The largest Envoy Medical buyer in Q1 2026 was Nantahala Capital Management, an estimated $5.22M added.
- The largest Envoy Medical seller in Q1 2026 was Citadel Advisors, an estimated $58.5K sold.
Based on aggregated 13F filings for Q1 2026.